ATCvet code: QI02AH

To stimulate an active immunity against Pi3, BRSV and BVDV Type 1.

The vaccine has a broad cross-neutralising ability against various current European strains of BVDV Type 1 as measured in vitro by virus neutralisation test. Cross neutralisation at a lower level has also been demonstrated to BVDV Type 2 strains.